Ani Pharmaceuticals Inc (ANIP) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ANIP.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
ANIP reports an average of 38.1% for its upside potential over the past 28 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ANIP Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ANIP has a higher upside potential (average analyst target price relative to current price) than 13.24% of Pharmaceutical Products stocks.
- Ani Pharmaceuticals Inc's average analyst price target is greater than 78.07% of stocks in the small market cap category.
- ANIP has a greater number of analysts covering the stock than 22.88% of Pharmaceutical Products stocks.
- ANIP has a lower variance in analysts' estimates than 28.71% of stocks in the small market cap category.
Is ANIP a Buy, Hold or Sell? See the POWR Ratings now!